29.74
+1.43%
Close of 9 Nov 2026, in HKD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Gushengtang Holdings
Its shares trade on HKEX under the ticker 2273.HK. It has been listed since 10 December 2021. In the fiscal year to 31 December 2025, it reported revenue of CN¥3.78bn and net income of CN¥410.5m. At that date it held total assets of CN¥4.65bn and shareholders' equity of CN¥2.53bn.
Gushengtang Holdings Ltd. operates the neo-TCM primary care platform, which combines inviting in-person care and seamless digital health powered by internet and AI technologies. The company is headquartered in Guangzhou, Guangdong. The company went IPO on 2021-12-10. The firm operates in two segments. Medical and Health Solutions segment is engaged in providing customers with traditional Chinese medical and health services through offline medical institutions and online medical and health platforms, including consultation, diagnosis, prescription services, decoctions and physical therapy. Sales of Medical and Health Products segment is mainly responsible for the sales of related products. The firm's main products include Ejiao, Cordyceps, cubilose, dendrobium, American Ginseng and other medicinal materials. The firm also provides honey, Ejiao cake and other nutritional products.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Health Care
- Industry
- Health Care Providers & Services
- Listed since
- 10 Dec 2021
- Employees
- 2,155
- Website
- www2.gstzy.cn ↗
Leadership
Pay as last reported
- Mr. Zhiliang TuExecutive Chairman of the Board, Chief Executive Officer, since 2014CN¥48.1m
- Mr. Shigang DengChief Financial Officer
- Ms. Jie LiVice President
- Mr. Xiang ZhengVice President
- Ms. Qiumin ZhangRegional General Manager
- Mr. Peng YuJoint Company Secretary
- Mr. Jian GaoNon-Executive DirectorCN¥175,000
- Mr. Jingsheng HuangNon-Executive DirectorCN¥175,000
- Mr. Kanghua LiuNon-Executive DirectorCN¥175,000
- Ms. Xu JinNon-Executive Independent Director
- Mr. Tie LiNon-Executive Independent Director
- Mr. Weihe ZhongNon-Executive Independent Director
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Gushengtang Holdings Ltd. employs 2,155 full-time employees in Guangzhou, China.
- The company operates a neo-TCM primary care platform combining in-person and digital health services.
- Gushengtang offers traditional Chinese medicinal products like Ejiao and Cordyceps.
Weaknesses
- The company's Medical and Health Products segment focuses on sales of medicinal materials and nutritional products.
- Gushengtang's business is limited to two segments: Medical and Health Solutions and Sales of Medical and Health Products.
- The firm's IPO was on 10 December 2021, showing recent market entry.
Opportunities
- Gushengtang can expand its digital health services in the growing Health Care sector in China.
- The company may leverage AI technologies to enhance its neo-TCM platform offerings.
- Increasing demand for traditional Chinese medicine in the Health Care industry presents growth potential.
Threats
- The Health Care sector in China faces regulatory challenges from government policies.
- Competition in the Health Care industry may intensify with new market entrants.
- Gushengtang's reliance on traditional Chinese medicinal products could be affected by changing consumer preferences.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.